RETRACTED: Breast Tumor Cells with PI3K Mutation or HER2 Amplification Are Selectively Addicted to Akt Signaling

Qing-Bai She, Sarat Chandarlapaty, Qing Ye et al. · 2008

Read RETRACTED: Breast Tumor Cells with PI3K Mutation or HER2 Amplification Are Selectively Addicted to Akt Signaling by Qing-Bai She, Sarat Chandarlapaty, Qing Ye et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0003065.txt.

Description

Qing-Bai She, Sarat Chandarlapaty, Qing Ye and co-authors studied breast tumor response to Akt signaling in a 2008 PLOS ONE article that was later retracted. Faulty PI3K/Akt signaling is common in breast cancers, arising from HER2 amplification, PI3K mutation, or PTEN loss. The objective was to test how Akt activation's role depends on which mechanism switched it on.

Readers should note the retraction status in the catalog title before citing any finding. The paper asked whether tumor cells with PI3K mutation or HER2 amplification depend selectively on Akt. Treat its claims as withdrawn unless independently confirmed elsewhere.

Catalog record

CREATORQing-Bai She, Sarat Chandarlapaty, Qing Ye et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE42 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0003065

Browse the full library · About the Tower of Babel